Schedule 13G ownership disclosure

Olema Pharmaceuticals Inc

Security class unavailable · CUSIP: 68062P106

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,019,109
Percent of class
5.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001678858-22-000194
Form type
SC 13G/A
Filer
Olema Oncology, Inc.
CIK
CIK 1750284
Filed
Feb 04, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub